These findings suggest that diabetes induces cardiomyocyte senescence via the miR-103a-3p/Rnd3/STAT3 signaling pathway, highlighting a potential therapeutic target for DCM. This evidence concerns the gene RND3 and familial dilated cardiomyopathy.